Cancel

Asthma Community Pharmacy Series

Asthma is a prevalent health condition with significant public health, quality of life, and economic consequences. With increasing numbers of respiratory delivery devices being used to deliver medication to the lung, pharmacists need to keep current on asthma devices. Pharmacists can help improve patient outcomes by identifying at-risk patients and intervening briefly to ensure proper inhalation technique. This series demonstrates evidence-based interventions that are sensitive to the const...
University of Maryland School of Pharmacy: CIPS Knowledge Enterprise

2016 Virtual Annual Meeting Recordings

Pre-order your 2016 Virtual Annual Meeting today! The AAAAI offers more than 300 educational sessions at the Annual Meeting each year. Because it's impossible to attend every session, and because many people are unable to attend, each year we offer select recordings from the live meeting in our Virtual Annual Meeting. These recordings are offered in two formats: streaming online and in MP4 format to download to your preferred device. Sessions that will be recorded will be marked with the fo...
American Academy of Allergy, Asthma & Immunology

The Role of the Pharmacist in Managing Severe Asthma

Asthma is a chronic obstructive respiratory disease that affects more than 300 million people world-wide and more than 25 million children and adults in the United States. Approximately 50% of patients with asthma struggle with "not well-controlled" or "poorly controlled" asthma. Around 10% of these patients have severe asthma and have an urgent need for improved care. Pharmacists can serve a critical role on the front lines of the health care community in the fight to get asthma under control...
freeCE.com

SEVERE ASTHMA: ENHANCING OUTCOMES THROUGH PHARMACIST INTERVENTION

Pharmacists are poised to expand their roles in asthma management, and there is much evidence indicating that doing so will improve outcomes, especially for patients with severe asthma. However, to do so pharmacists will need education regarding the current state of severe asthma management and emerging targeted biologic therapies. Pharmacists also need education on how to overcome barriers such as low patient confidence and interest in pharmacists as asthma management specialists, low pharmac...
American Academy of CME

Dispensing Opioids: Decisions to Improve Medication Safety

At the time of dispensing, health professionals are exposed to patients who are struggling with uncontrolled asthma or poorly controlled COPD. Caregivers are also seeking better ways to management this chronic condition. The online module entitled Optimizing Patient Use of Inhalers and Other Respiratory Devices will equip learners with a practical understanding of devices to deliver drug to the lungs. Video demonstrations help learners become familiar with how to identify poor inhaler techniq...
University of Maryland School of Pharmacy: CIPS Knowledge Enterprise

Severe Asthma Virtual Practice: Clinical Phenotypes and the Emerging Age of Personalized Therapy

Up to 10% of asthma patients have severe, treatment-resistant disease that is associated with a greater incidence of emergency room visits, hospitalizations, and other high-risk outcomes. Often, these patients are only responsive to corticosteroid treatment when it is given at very high doses, which over time can lead to type 2 diabetes, osteoporosis, dyspeptic disorders, and cataracts. The FDA’s approval of several new tailored biologic therapies offers promise to a subset of patients with ...
RedMedEd and Rutgers Biomedical and Health Sciences

RME Hot Seat – Severe Asthma: Clinical Phenotypes and the Emerging Age of Personalized Therapy

Patients with severe treatment-resistant asthma—estimated to account for 4%–10% of all asthma cases—are characterized by persistent symptoms, compromised lung function, and a significantly increased frequency and severity of high-risk outcomes. These patients are typically insensitive to corticosteroid treatment, except at very high doses—and are thus at greater risk for several serious diseases, including type 2 diabetes and osteoporosis. This elevated risk for morbidity underscores t...
RedMedEd and Rutgers Biomedical and Health Sciences

Physician Dispensing: Optimizing Patient Use of Inhalers and Other Respiratory Devices

At the time of dispensing, health professionals are exposed to patients who are struggling with uncontrolled asthma or poorly controlled COPD. Caregivers are also seeking better ways to management this chronic condition. The online module entitled Optimizing Patient Use of Inhalers and Other Respiratory Devices will equip learners with a practical understanding of devices to deliver drug to the lungs. Video demonstrations help learners become familiar with how to identify poor inhaler techniq...
University of Maryland School of Pharmacy: CIPS Knowledge Enterprise

The Brigham Board Review in Allergy & Immunology

Topics covered by The Brigham Board Review in Allergy and Immunology include: T Cells and Innate Lymphoid Cells, B Cells and Antibody Formation, Lipid Mediators in Allergic Disease, Regulatory T Cells, Mucosal Immunity and the Microbiome, Diagnosis and Management of Asthma, Atopic Dermatitis, Drug Allergy and dozens more. After completing The Brigham Board Review in Allergy and Immunology, you will be better able to: • Integrate and demonstrate increased overall knowledge of allergy/immun...
CMEInfo

Asthma Management and Education

Overview: The Asthma Management and Education course is structured around NAEPP’s “Four Components of Asthma Management.” Allied Health professionals who complete the course will expand their knowledge of these four components which include: information on assessment and monitoring, control of environmental factors, pharmacologic management, and patient education. Course Outline: I. Introduction Facts about Asthma Myths about Asthma II. Assessment and Monitoring Diagnos...
Asthma and Allergy Foundation of America

RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.